Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

• Status: Completed
• Trial end date: 1994-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of the study is to quantitatively evaluate pituitary hormone response, follicle stimulating hormone (FSH) and luteinizing hormone (LH), to low doses of clomiphene citrate in normally fertile women.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Collaborator: Mayo Clinic
• Treatments: Citric Acid; Clomiphene; Enclomiphene; Follicle Stimulating Hormone; Hormones; Zuclomiphene

Criteria

Inclusion Criteria:

• Normal cycling healthy women with known fertility

• Regular menses every 24 - 35 days

• 18 to 35 years of age

• be within 20% of ideal body weight

• normal TSH, prolactin and mid luteal phase progesterone

Exclusion Criteria:

• Women with Infertility issues

• Irregular menstrual cycles